|
Cours en clôture
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,0640 USD | +2,56% |
|
-46,67% | -30,81% |
| 29/08/25 | Altamira Therapeutics Ltd. publie ses résultats semestriels au 30 juin 2025 | CI |
| 29/08/25 | Transcript : Altamira Therapeutics Ltd., H1 2025 Earnings Call, Aug 29, 2025 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2,56% | -46,67% | -16,88% | +27,49% | -30,81% | -32,56% | -99,50% | -100,00% | -100,00% | 357 k | |
| +1,86% | +7,65% | +14,07% | +29,75% | +12,96% | +55,77% | +158,84% | +418,85% | +1 437,57% | 1 063 Md | |
| +3,57% | +7,42% | +18,01% | +8,23% | +27,10% | +69,09% | +58,92% | +55,66% | +116,87% | 611 Md | |
| +3,99% | +7,37% | +21,20% | +25,01% | +14,26% | +36,87% | +93,77% | +126,68% | +316,31% | 444 Md | |
| -1,20% | -1,94% | +6,17% | +3,40% | +0,18% | +26,41% | +20,22% | -5,94% | +28,09% | 324 Md | |
| +4,94% | +3,39% | +10,02% | -5,08% | +5,42% | +39,92% | +28,93% | +65,60% | +222,89% | 285 Md | |
| +2,42% | +1,60% | +13,29% | +3,91% | +16,81% | +30,06% | +42,24% | +51,47% | +59,13% | 283 Md | |
| +2,47% | +5,18% | +19,58% | +40,14% | +2,08% | -24,80% | -39,60% | +25,19% | +82,67% | 219 Md | |
| +3,55% | +6,05% | +13,98% | +7,53% | +14,31% | +26,04% | +68,52% | +50,44% | +142,51% | 195 Md | |
| +4,21% | +6,00% | +2,90% | -6,04% | +6,95% | +17,72% | +70,33% | +89,42% | +54,69% | 156 Md | |
| +1,84% | +2,75% | -4,81% | -14,12% | -2,33% | -3,95% | -33,70% | -38,79% | -31,63% | 136 Md | |
| +6,03% | +9,97% | +24,22% | +20,36% | +16,47% | +15,54% | +50,05% | +163,31% | +501,82% | 126 Md | |
| +4,16% | +4,95% | +6,74% | -2,47% | +7,77% | +22,04% | -9,10% | -13,17% | -21,21% | 115 Md | |
| +3,83% | +1,03% | +10,08% | -6,53% | +9,84% | +42,18% | +44,30% | +11,50% | +0,20% | 102 Md | |
| +3,01% | +2,02% | +2,49% | -8,88% | -9,03% | -10,00% | -23,37% | -14,39% | +0,31% | 99,86 Md | |
| +5,24% | +4,99% | +5,15% | -11,09% | -5,31% | +10,93% | +89,26% | +80,21% | +524,40% | 73,78 Md | |
| +8,90% | +13,53% | +56,48% | +34,42% | +44,18% | +102,47% | +5,31% | +3,67% | -41,16% | 54,83 Md | |
| -0,54% | +6,89% | +10,52% | -6,76% | -10,21% | +2,37% | +11,67% | -20,06% | +257,80% | 52,27 Md | |
| +3,60% | +7,39% | +15,06% | -5,84% | +12,99% | +23,51% | +20,15% | +47,17% | +21,89% | 50,1 Md | |
| +2,82% | +3,50% | +12,31% | -3,35% | -3,84% | -3,25% | +11,84% | - | - | 41,03 Md | |
| Moyenne | +3,12% | +1,70% | +12,03% | +6,50% | +6,49% | +22,32% | +28,45% | +52,47% | +188,06% | 221,62 Md | |
| Moyenne pondérée par Capi. | +2,25% | +4,84% | +13,81% | +12,84% | +11,76% | +36,92% | +67,85% | +140,52% | +453,41% |
- Bourse
- Actions
- Action CYTO.F
- Secteur Altamira Therapeutics Ltd.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
